FDA Inspection 1111580 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3007044092

The FDA completed an inspection of Biomat USA, Inc. on October 22, 2019 in Lakewood, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 22, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lakewood, CO (United States)